A detailed history of Capital Advisors, Ltd. LLC transactions in Viatris Inc stock. As of the latest transaction made, Capital Advisors, Ltd. LLC holds 649 shares of VTRS stock, worth $8,047. This represents 0.0% of its overall portfolio holdings.

Number of Shares
649
Previous 645 0.62%
Holding current value
$8,047
Previous $7,000 14.29%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$10.32 - $12.13 $41 - $48
4 Added 0.62%
649 $8,000
Q2 2024

Jul 25, 2024

BUY
$10.05 - $12.02 $30 - $36
3 Added 0.47%
645 $7,000
Q1 2024

Apr 18, 2024

BUY
$11.27 - $13.53 $45 - $54
4 Added 0.63%
642 $8,000
Q4 2023

Feb 02, 2024

SELL
$8.77 - $10.85 $192 - $238
-22 Reduced 3.33%
638 $7,000
Q3 2023

Oct 27, 2023

SELL
$9.59 - $11.35 $2,234 - $2,644
-233 Reduced 26.09%
660 $7,000
Q2 2023

Jul 26, 2023

BUY
$9.02 - $10.29 $3,860 - $4,404
428 Added 92.04%
893 $9,000
Q1 2023

May 03, 2023

SELL
$9.2 - $12.26 $3,873 - $5,161
-421 Reduced 47.52%
465 $4,000
Q4 2022

Feb 07, 2023

SELL
$8.72 - $11.56 $270 - $358
-31 Reduced 3.38%
886 $10,000
Q3 2022

Nov 09, 2022

BUY
$8.48 - $11.13 $1,272 - $1,669
150 Added 19.56%
917 $8,000
Q2 2022

Aug 05, 2022

BUY
$9.95 - $12.27 $726 - $895
73 Added 10.52%
767 $8,000
Q1 2022

May 09, 2022

SELL
$9.81 - $15.4 $5,572 - $8,747
-568 Reduced 45.01%
694 $8,000
Q4 2021

Feb 08, 2022

BUY
$12.09 - $14.68 $1,656 - $2,011
137 Added 12.18%
1,262 $17,000
Q3 2021

Nov 12, 2021

BUY
$13.25 - $15.13 $53 - $60
4 Added 0.36%
1,125 $15,000
Q2 2021

Aug 10, 2021

SELL
$12.97 - $16.15 $2,049 - $2,551
-158 Reduced 12.35%
1,121 $16,000
Q1 2021

May 13, 2021

SELL
$13.59 - $18.54 $190 - $259
-14 Reduced 1.08%
1,279 $18,000
Q4 2020

Feb 10, 2021

BUY
$14.3 - $18.74 $18,489 - $24,230
1,293 New
1,293 $24,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Capital Advisors, Ltd. LLC Portfolio

Follow Capital Advisors, Ltd. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisors, Ltd. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisors, Ltd. LLC with notifications on news.